Skip to content

Envoy Medical COCH Deferred Tax Assets, Operating Loss Carryforwards

Deferred Tax Assets, Operating Loss Carryforwards at other companies

L3Harris Technologies logo
L3Harris TechnologiesLHX
$37M-54.3%
General Dynamics logo
General DynamicsGD
$663M+5.2%
Popular logo
PopularBPOP
$627.73M-5.2%
Siebert Financial logo
Siebert FinancialSIEB
$3.7M
BCB Bancorp logo
BCB BancorpBCBP
$2.54M+138%
ROC
Rank One Computing ROC
$2.04K

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's deferred tax assets, operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's deferred tax assets, operating loss carryforwards?
Envoy Medical (COCH) reported deferred tax assets, operating loss carryforwards of $42.3M in Q4 2025.
What is the long-term trend for Envoy Medical's deferred tax assets, operating loss carryforwards?
Over 3 years (2022 to 2025), Envoy Medical's deferred tax assets, operating loss carryforwards has grown at a 1.6% compound annual growth rate (CAGR), from $40.3M to $42.3M.